Exploratory trial of Levo-Carnicin for metabolism in patients with\ Crohn's disease

Exploratory trial of Levo-Carnicin for metabolism in patients with\ Crohn's disease - Exploratory trial of Levo-Carnicin for metabolism in patients with\ Crohn's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026099

Enrollment

Registered

2017-04-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

Levo-Carnicin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Crohn's disease

Exclusion criteria

Exclusion criteria: Patients who was treated diabetes medication

Design outcomes

Primary

Measure	Time frame
Effect of Levo-Carnicin in patients with Crohn's disease	—

Countries

Japan

Contacts

Public ContactKazuhiro Watanabe

Tohoku University Gastrointestinal Surgery

k-wata@surg1.med.tohoku.ac.jp022-717-7205

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Exploratory trial of Levo-Carnicin for metabolism in patients with\ Crohn&#39;s disease